Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders (2018) Kaehler KC, Eigentler TK, Gesierich A, Heinzerling L, Loquai C, Meier F, Meiss F, et al. Journal article High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients (2018) Breyer J, Wirtz RM, Otto W, Erben P, Worst TS, Stoehr R, Eckstein M, et al. Journal article Intralesional interleukin-2 for unresectable mucosal melanoma refractory to nivolumab (2017) Heppt MV, Goldscheider I, Tietze JK, Berking C Journal article Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1 (2017) Rathinasamy A, Domschke C, Ge Y, Boehm HH, Dettling S, Jansen D, Lasitschka F, et al. Journal article Targeting of the WT191–138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination (2017) Dagvadorj N, Deuretzbacher A, Weisenberger D, Baumeister E, Trebing J, Lang I, Koechel C, et al. Journal article Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls (2017) Goebel S, Kehlen A, Bluemke K, Altermann W, Schlaf G, Fischer K, Fornara P, et al. Journal article CD8+ T-cell priming and boosting: More antigen-presenting DC, or more antigen per DC? (2013) Schaft N, Wellner V, Wohn C, Schuler G, Dörrie J Journal article Survivin-specific T-cell reactivity correlates with tumor response and patient survival: A phase-II peptide vaccination trial in metastatic melanoma (2012) Becker JC, Andersen MH, Hofmeister-Mueller V, Wobser M, Frey L, Sandig C, Walter S, et al. Journal article, Original article